Опыт применения престанса у больных ишемической болезнью сердца в сочетании с соматической патологией

А. В. Никитин, Елена Владимировна Гостева, Х. А. Булуева et al. · Вестник новых медицинских технологий · 2013

To study the effect of treatment by the Prestans (Society Servier, France) in the dose of 10/5 mg per day on the state of cardiorespiratory system, 32 patients (age 56,3±1,8 years) with the coronary heart disease in combination with arterial hypertension and chronic obstructive bronchitis were examined. The 24-hour ECG and BP monitoring, the echocardiograhy, the evaluation of FEV, and of blood gases were performed before the treatment and in the 6 th week of treatment. A combined favorable effect of the Prestans was shown in respect of the coronary circulation, bronchial obstruction, degree of respiratory failure, cardiac arrhythmias as well as on the level of systemic and pulmonary hypertensions.

Cited by 0 works.

Authors